What is the definition of acute liver injury?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition of Acute Liver Injury

Acute liver injury is defined by any of the following criteria: 1) Alanine aminotransferase (ALT) level ≥5x upper limit of normal (ULN), 2) Alkaline phosphatase (ALP) level ≥2 ULN (particularly with elevated gamma-glutamyl transpeptidase in the absence of bone disease), or 3) ALT level ≥3 ULN with simultaneous total bilirubin level >2 ULN. 1

Diagnostic Criteria

The definition of acute liver injury includes specific laboratory thresholds:

  • ALT level ≥5x upper limit of normal (ULN) 1
  • ALP level ≥2 ULN (particularly if concomitantly elevated GGT in the absence of bone disease) 1
  • ALT level ≥3 ULN and simultaneous total bilirubin (TB) level >2 ULN 1

For patients with abnormal baseline liver tests, the ULN should be replaced by the mean baseline values obtained prior to exposure to the suspect agent, and increases should be proportionate to this modified baseline 1.

Pattern Classification

Acute liver injury can be further classified according to the R value, which is defined as: (ALT/ULN)/(ALP/ULN) 1:

  • Hepatocellular pattern: R ≥5 1
  • Cholestatic pattern: R ≤2 1
  • Mixed pattern: R value >2 and <5 1

Note: AST can replace ALT when ALT is unavailable 1.

Clinical Presentations

Acute liver injury may present with various histological patterns depending on the causative agent:

  • Hepatocellular necrosis: Most common form, involving hepatic parenchyma and producing hepatocellular jaundice 1
  • Cholestatic/mixed injury: Seen with certain toxins like methylenedianiline and paraquat 1
  • Microvesicular steatosis: Characterized by tiny fat droplets in hepatocyte cytoplasm 1
  • Toxicant-associated steatohepatitis (TASH): Characterized by steatosis, inflammatory infiltrates, and ballooning hepatocytes 1

Severity Grading

The severity of acute liver injury can be graded as follows 1:

  • Grade 1: Elevated ALT/ALP meeting criteria for liver injury but bilirubin <2 ULN 1
  • Grade 2: Elevated ALT/ALP meeting criteria for liver injury and bilirubin ≥2 ULN, or symptomatic hepatitis 1
  • Grade 3: Elevated ALT/ALP meeting criteria for liver injury, bilirubin ≥2 ULN, and one of the following:
    • INR ≥1.5
    • Ascites and/or encephalopathy (without underlying cirrhosis)
    • Other organ failure due to liver injury 1
  • Grade 4: Death or transplantation due to liver injury 1

Important Considerations

  • Isolated increases in GGT activity are not markers of cellular damage but rather indicate enzyme induction 1
  • The values used for classification should be those available when liver injury is first recognized 1
  • Due to differences in clearance kinetics of ALT and ALP, the injury pattern may shift to a cholestatic/mixed signature over time 1
  • In occupational liver diseases, the standard classification used for idiosyncratic drug-induced acute liver failure may not apply due to the direct, massive, and rapid liver damage induced by chemicals 1
  • Fulminant liver failure with symptoms appearing 24-48 hours after chemical exposure may occur with certain toxins 1

Clinical Implications

  • Acute liver injury can progress to acute liver failure if not properly managed 2
  • Early recognition and discontinuation of the offending agent is crucial 3
  • N-acetylcysteine may be indicated to prevent or lessen hepatic injury in cases of acetaminophen toxicity 4
  • The ALT/LD ratio can help differentiate between viral hepatitis and other causes of acute liver injury 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Liver Failure Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Acute Hepatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.